Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 62%
Hold 5%
Sell 5%
Strong Sell 0%

Bulls say

UnitedHealth Group is a strong performer in the private health insurance industry due to its massive scale, diverse business segments, and strong balance sheet with significant free cash flow. With the recovery of its Optum Health segment and potential for margin growth, the company has strong potential for earnings growth in the future. Additionally, its investments in AI and technology further enhance its competitive advantage. However, risks to its outlook include exposure to government contracts, regulatory changes, and competition. Overall, a Buy rating is recommended with a price target of $395 based on the company's current and potential future earnings.

Bears say

UnitedHealth Group is a leading player in the medical insurance industry, with diversified assets and earnings across various lines of business. However, there are downside risks to their future growth, including potential reimbursement reductions and increased competition in the Medicare Advantage market, as well as regulatory risks for their pharmacy benefits management operations. As a result, the outlook for UnitedHealth Group's stock is negative, with concerns about potential margin pressures and potential impact on earnings growth.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 62% recommend Buy, 5% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $415.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $415.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.